Bey-Douglas LLC’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$321K Buy
3,704
+109
+3% +$10.4K 0.28% 41
2025
Q4
$345K Buy
3,595
+365
+11% +$35.5K 0.28% 33
2025
Q3
$308K Buy
3,230
+61
+2% +$5.61K 0.23% 41
2025
Q2
$276K Buy
3,169
+869
+38% +$73.7K 0.17% 38
2025
Q1
$207K Buy
+2,300
New +$206K 0.19% 38

Other funds holding MDT

Bey-Douglas LLC's MDT Position: Q1 2026 in Review

Bey-Douglas LLC increased its Medtronic (MDT) stake by 3% in Q1 2026, buying an estimated $10.4K and bringing the position to 3,704 shares worth $321K. The position accounts for 0.28% of the portfolio, ranked #41.

Bey-Douglas LLC first reported a position in MDT in Q1 2025 and has held it in 5 quarters since. The position peaked at $345K in Q4 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Bey-Douglas LLC held 3,704 shares of Medtronic worth $321K as of Q1 2026.
  • Bey-Douglas LLC bought 109 Medtronic shares in Q1 2026, an estimated $10.4K.
  • Medtronic made up 0.28% of Bey-Douglas LLC's portfolio in Q1 2026, its #41 holding.
  • Bey-Douglas LLC first reported a position in Medtronic in Q1 2025 and has held it in 5 quarters since.
  • Bey-Douglas LLC's Medtronic position peaked at $345K in Q4 2025.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Bey-Douglas LLC's 13F filing for Q1 2026, filed 12 May 2026.